Bank Of New York Mellon Corp Prothena Corp Public LTD CO Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$52.05 - $65.0 $7.13 Million - $8.9 Million	136,997 New	136,997 $8.25 Million
Q3 2022 Nov 14, 2022	BUY	$25.16 - $60.63 $524,032 - $1.26 Million	20,828 Added 17.45%	140,192 $8.5 Million
Q2 2022 Aug 15, 2022	SELL	$22.73 - $39.98 $793,663 - $1.4 Million	-34,917 Reduced 22.63%	119,364 $3.24 Million
Q1 2022 May 11, 2022	BUY	$30.27 - $49.22 $55,121 - $89,629	1,821 Added 1.19%	154,281 $5.64 Million
Q4 2021 Feb 11, 2022	BUY	$42.11 - $73.26 $638,935 - $1.11 Million	15,173 Added 11.05%	152,460 $7.53 Million
Q3 2021 Nov 12, 2021	BUY	$48.2 - $78.89 $88,302 - $144,526	1,832 Added 1.35%	137,287 $9.78 Million
Q2 2021 Aug 11, 2021	BUY	$21.63 - $57.65 $117,991 - $314,480	5,455 Added 4.2%	135,455 $6.96 Million
Q1 2021 May 13, 2021	SELL	$11.0 - $28.24 $104,742 - $268,901	-9,522 Reduced 6.82%	130,000 $3.27 Million
Q4 2020 Feb 09, 2021	SELL	$10.12 - $13.94 $92,699 - $127,690	-9,160 Reduced 6.16%	139,522 $1.68 Million
Q3 2020 Nov 12, 2020	SELL	$9.93 - $13.47 $107,909 - $146,378	-10,867 Reduced 6.81%	148,682 $1.49 Million
Q2 2020 Aug 12, 2020	SELL	$9.56 - $12.51 $1.65 Million - $2.16 Million	-172,891 Reduced 52.01%	159,549 $1.67 Million
Q1 2020 May 06, 2020	SELL	$7.54 - $15.77 $30,702 - $64,215	-4,072 Reduced 1.21%	332,440 $3.56 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $17.01 $20,068 - $45,637	2,683 Added 0.8%	336,512 $5.33 Million
Q3 2019 Nov 07, 2019	SELL	$6.89 - $10.45 $37,777 - $57,297	-5,483 Reduced 1.62%	333,829 $2.62 Million
Q2 2019 Aug 12, 2019	SELL	$8.85 - $12.49 $196,257 - $276,978	-22,176 Reduced 6.13%	339,312 $3.59 Million
Q1 2019 May 14, 2019	SELL	$10.32 - $14.49 $119,546 - $167,852	-11,584 Reduced 3.11%	361,488 $4.38 Million
Q4 2018 Feb 11, 2019	BUY	$8.73 - $13.74 $1.48 Million - $2.32 Million	169,070 Added 82.88%	373,072 $3.84 Million
Q3 2018 Nov 09, 2018	BUY	$12.7 - $15.79 $202,018 - $251,171	15,907 Added 8.46%	204,002 $0
Q2 2018 Aug 06, 2018	BUY	$10.99 - $44.21 $97,173 - $390,904	8,842 Added 4.93%	188,095 $2.74 Million
Q1 2018 May 15, 2018	BUY	$27.95 - $45.04 $95,169 - $153,361	3,405 Added 1.94%	179,253 $6.58 Million
Q4 2017 Feb 09, 2018	BUY	$35.44 - $63.76 $6.23 Million - $11.2 Million	175,848	175,848 $6.59 Million

Others Institutions Holding PRTA

# of Institutions

185

Shares Held

42.8M

Call Options Held

162K

Put Options Held

102K

Eco R1 Capital, LLC San Francisco, CA

11.6M
Shares

$165 Million
8.41% of portfolio
Wellington Management Group LLP Boston, MA

4.18M
Shares

$59.5 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.86M
Shares

$54.9 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.82M
Shares

$54.4 Million
0.01% of portfolio
Palo Alto Investors LP Palo Alto, CA

1.74M
Shares

$24.7 Million
4.0% of portfolio

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $668M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account